Polymorphism of dextromethorphan oxidation in a French population
about
Pharmacokinetics of sabeluzole and dextromethorphan oxidation capacity in patients with severe hepatic dysfunction and healthy volunteersPharmacogenetics and psychopharmacotherapy.The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomesThe effect of inhaled and oral dextromethorphan on citric acid induced cough in manLack of a relationship between the polymorphism of debrisoquine oxidation and lung cancerDextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathy.Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant.Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolismA validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects.
P2860
Q28361024-20DB2F42-3D39-45A7-AC03-4D29ED619F62Q33962212-E2FDA72B-5A79-40C1-8FC7-C67B3FD9E2D7Q34346292-F10BEB36-28E4-475D-A006-90000F99BC52Q34347009-748F7686-379E-42D8-A9C3-533DA4A7C394Q34358477-05122C7C-64CD-439D-A0D2-A96FCF9C8939Q34397246-02CE776C-2D42-481A-BB18-65267B7026C0Q34397478-4B3B818D-AD39-4390-B40B-BA403C3513EFQ34397748-D784069D-5D25-40DB-B75E-876C8FF272EBQ34400605-99FC9814-817E-4644-9ADD-467DB4996EC0Q34403471-9EFBF8EF-7943-4AE2-90AB-AE38CD06D566Q38260323-A91DA8F5-CB4E-465B-9D78-74C440CD0D83Q42198417-A6BA1E73-F41A-48AC-AC16-55DBA2E3508CQ42285032-55764991-EA64-4E65-B6E1-7348D00D042DQ46010800-2E26D751-A489-430F-A6AD-7B4CB03685B0Q46825567-099A3EB3-E4A6-42A4-9A74-F1378D4C2A71
P2860
Polymorphism of dextromethorphan oxidation in a French population
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Polymorphism of dextromethorphan oxidation in a French population
@ast
Polymorphism of dextromethorphan oxidation in a French population
@en
Polymorphism of dextromethorphan oxidation in a French population
@nl
type
label
Polymorphism of dextromethorphan oxidation in a French population
@ast
Polymorphism of dextromethorphan oxidation in a French population
@en
Polymorphism of dextromethorphan oxidation in a French population
@nl
prefLabel
Polymorphism of dextromethorphan oxidation in a French population
@ast
Polymorphism of dextromethorphan oxidation in a French population
@en
Polymorphism of dextromethorphan oxidation in a French population
@nl
P2093
P2860
P1476
Polymorphism of dextromethorphan oxidation in a French population
@en
P2093
Letteron P
Pessayre D
P2860
P304
P356
10.1111/J.1365-2125.1987.TB03230.X
P407
P577
1987-11-01T00:00:00Z